Cargando…
Immunotherapy of acute leukemia by chimeric antigen receptor-modified lymphocytes using an improved Sleeping Beauty transposon platform
Chimeric antigen receptor (CAR)-modified T-cell adoptive immunotherapy is a remarkable therapeutic option proven effective in the treatment of hematological malignancies. In order to optimize cell manufacturing, we sought to develop a novel clinical-grade protocol to obtain CAR-modified cytokine-ind...
Autores principales: | Magnani, Chiara F., Turazzi, Nice, Benedicenti, Fabrizio, Calabria, Andrea, Tenderini, Erika, Tettamanti, Sarah, Attianese, Greta M.P. Giordano, Cooper, Laurence J.N., Aiuti, Alessandro, Montini, Eugenio, Biondi, Andrea, Biagi, Ettore |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5239498/ https://www.ncbi.nlm.nih.gov/pubmed/27323395 http://dx.doi.org/10.18632/oncotarget.9955 |
Ejemplares similares
-
Advanced Targeted, Cell and Gene-Therapy Approaches for Pediatric Hematological Malignancies: Results and Future Perspectives
por: Magnani, Chiara F., et al.
Publicado: (2013) -
New advances in leukaemia immunotherapy by the use of Chimeric Artificial Antigen Receptors (CARs): state of the art and perspectives for the near future
por: Biagi, Ettore, et al.
Publicado: (2011) -
adLIMS: a customized open source software that allows bridging clinical and basic molecular research studies
por: Calabria, Andrea, et al.
Publicado: (2015) -
CD123 AML targeting by chimeric antigen receptors: A novel magic bullet for AML therapeutics?
por: Tettamanti, Sarah, et al.
Publicado: (2014) -
γ-TRIS: a graph-algorithm for comprehensive identification of vector genomic insertion sites
por: Calabria, Andrea, et al.
Publicado: (2020)